Platypus Technologies Competitors

A trusted partner for millions of customers, Ecolab (NYSE:ECL) is a global sustainability leader offering water, hygiene and infection prevention solutions and services that protect people and the resources vital to life. Building on more than a century of innovation, Ecolab has annual sales of $16 billion, employs approximately 48,000 associates and operates in more than 170 countries around the world. The company delivers comprehensive science-based solutions, data-driven insights and world-class service to advance food safety, maintain clean and safe environments, and optimize water and energy use. Ecolab’s innovative solutions improve operational efficiencies and sustainability for customers in the food, healthcare, high tech, life sciences, hospitality and industrial markets. For more Ecolab news and information, visit www.ecolab.com.

Medline is the largest provider of medical-surgical products and supply chain solutions serving all points of care. Through its unique offering of world-class products, supply chain resilience and clinical practice expertise, Medline delivers improved clinical, financial and operational outcomes. Headquartered in Northfield, Illinois, the company employs 43,000 people worldwide and operates in over 100 countries and territories. To learn more about how Medline makes healthcare run better, visit www.medline.com.

Nova Biomedical is entering a new chapter. Advanced Instruments and Nova Biomedical have united to form a larger, more focused global life science tools company operating under the Nova Biomedical name. By bringing together two innovation‑driven organizations, we have expanded our capabilities across bioprocessing and clinical diagnostics, strengthening how we serve customers and accelerating our impact across life sciences. Today’s Nova Biomedical is a global leader in supporting bioprocessing workflows and in vitro diagnostics (IVD), guided by a renewed leadership team, sharper priorities, and a clear focus on innovation, quality, and customer outcomes. We are committed to advancing patient care and scientific discovery through reliable, high‑performance technologies backed by disciplined execution and long‑term investment. Our portfolio includes: Clinical Diagnostics: Blood gas, critical care, and glucose analyzers that deliver fast, accurate results to support confident clinical decisions. Bioprocessing Solutions: Cell line development solutions, real‑time cell culture monitoring and process optimization, helping customers improve productivity, quality, and scale. Veterinary Diagnostics: High‑performance diagnostic solutions designed for animal health applications. We reinvest annually into research and development, fueling a strong pipeline of breakthrough technologies and reinforcing our leadership in innovation. As the largest privately held IVD company in the U.S. and one of the fastest‑growing globally, Nova Biomedical serves customers in more than 100 countries. Our culture is grounded in integrity, accountability, and long‑term commitment, values reflected in the trust of our customers and the dedication of our people. As a new Nova Biomedical, we are focused on delivering consistent quality, meaningful innovation, and lasting impact—today and for what’s next. Learn more: www.novabiomedical.com